Financial results for the period ended September 30, 2026
As filed · Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
EarningsMajormateriality 75 out of 100
What happened
FactFinancial results for the period ended September 30, 2026. Unaudited Financial Results of the Company for the quarter and half year ended 30th September. Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnEarlierQ3 FY26
largely, our estimate is we'll grow at 14% CAGR over the next 5 years.
NowQ1 FY27
we feel confident that this year would not be impacted.
Change
FactGuidance withdrawn
Implication
CapitSignal interpretationThe earlier statement projected a 14% CAGR growth over the next 5 years, while the current statement does not provide any growth target, indicating a withdrawal of guidance.confidence 90%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- FY '27 will be 35% to 38%, you can say, because we'll be coming out of MAT after March '26. (management committed by FY27)
- FY '28 is when we will break even. But the amount will be not very significant from Medtech in terms of opex l (management committed by FY28)
Evidence
- Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q3 FY26
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%